McGuire, A.; Casey, M.-C.; Waldron, R.M.; Heneghan, H.; Kalinina, O.; Holian, E.; McDermott, A.; Lowery, A.J.; Newell, J.; Dwyer, R.M.;
et al. Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer. Cancers 2020, 12, 1820.
https://doi.org/10.3390/cancers12071820
AMA Style
McGuire A, Casey M-C, Waldron RM, Heneghan H, Kalinina O, Holian E, McDermott A, Lowery AJ, Newell J, Dwyer RM,
et al. Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer. Cancers. 2020; 12(7):1820.
https://doi.org/10.3390/cancers12071820
Chicago/Turabian Style
McGuire, Andrew, Maire-Caitlin Casey, Ronan M. Waldron, Helen Heneghan, Olga Kalinina, Emma Holian, Ailbhe McDermott, Aoife J. Lowery, John Newell, RóisÃn M. Dwyer,
and et al. 2020. "Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer" Cancers 12, no. 7: 1820.
https://doi.org/10.3390/cancers12071820
APA Style
McGuire, A., Casey, M. -C., Waldron, R. M., Heneghan, H., Kalinina, O., Holian, E., McDermott, A., Lowery, A. J., Newell, J., Dwyer, R. M., Miller, N., Keane, M., Brown, J. A. L., & Kerin, M. J.
(2020). Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer. Cancers, 12(7), 1820.
https://doi.org/10.3390/cancers12071820